Clinical outcome using the Q300™ device in a reproductive laboratory environment: an open-label, non-controlled and...

Area of Science:

• Reproductive Medicine
• Andrology
• Embryology

Background:

• Male factor infertility impacts nearly half of all infertility cases globally.
• Assisted reproductive technologies (ART) success relies on selecting sperm with optimal motility, morphology, and DNA integrity.
• The Q300™ device utilizes advanced optical imaging for improved sperm selection.

Purpose of the Study:

• To assess the usability of the Q300™ device in a fertility laboratory setting.
• To evaluate the preliminary clinical outcomes of the Q300™ device under real-life conditions.
• To determine the impact of the Q300™ on key performance indicators in ART.

Main Methods:

• Preliminary clinical data were collected from Barzilai Medical Center.
• Data were compared between cycles with and without the Q300™ device.
• Outcomes were assessed against Key Performance Indicators (KPI) for ART laboratories per the Vienna Consensus.

Main Results:

• The Q300™ device significantly improved day-3 embryo development.
• Enhanced blastulation rates were observed with Q300™ use.
• Cumulative pregnancy rates were significantly higher when using the Q300™ device.

Conclusions:

• The Q300™ offers a refined and efficient sperm selection process.
• This technology has the potential to redefine clinical practice in infertility treatment.
• The Q300™ may increase the likelihood of successful outcomes for patients undergoing ART.